AAP News Vol. 13 No. 8 August 1997, p. 2
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Growth hormone, apnea

In rare cases, children treated with recombinant growth hormone face a risk of obstructive and central sleep apnea, according to Missouri researchers.

Of 145 pediatric patients receiving growth hormone therapy at a St. Louis children's hospital, four developed sleep apnea despite having no history of sleep disorders.

Tonsils and adenoids in the four patients were normal size before GH treatment.